HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,006 | +1.2% | 778 | -10.1% | 0.01% | 0.0% |
| Q2 2023 | $88,965 | -7.7% | 865 | -2.0% | 0.01% | 0.0% |
| Q1 2023 | $96,370 | -45.8% | 883 | -43.5% | 0.01% | -50.0% |
| Q4 2022 | $177,869 | – | 1,563 | – | 0.01% | – |
| Q3 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $172,000 | -13.6% | 2,153 | +14.1% | 0.02% | 0.0% |
| Q1 2022 | $199,000 | -17.1% | 1,887 | -15.2% | 0.02% | +7.1% |
| Q4 2021 | $240,000 | +4.8% | 2,224 | +6.3% | 0.01% | 0.0% |
| Q3 2021 | $229,000 | +19.9% | 2,092 | +2.5% | 0.01% | +16.7% |
| Q2 2021 | $191,000 | -14.3% | 2,040 | -15.7% | 0.01% | -25.0% |
| Q1 2021 | $223,000 | +31.2% | 2,420 | +3.9% | 0.02% | +23.1% |
| Q4 2020 | $170,000 | +40.5% | 2,329 | +50.0% | 0.01% | +18.2% |
| Q3 2020 | $121,000 | +536.8% | 1,553 | +346.3% | 0.01% | +450.0% |
| Q2 2020 | $19,000 | +90.0% | 348 | +3.6% | 0.00% | +100.0% |
| Q1 2020 | $10,000 | +25.0% | 336 | +50.7% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | +166.7% | 223 | +102.7% | 0.00% | 0.0% |
| Q3 2019 | $3,000 | -50.0% | 110 | -53.2% | 0.00% | 0.0% |
| Q2 2019 | $6,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |